|
CDCA8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.2443000004595E-07 |
| Normal-vs-Stage2 |
3.612000E-02 |
| Normal-vs-Stage3 |
4.48350000004094E-06 |
| Normal-vs-Stage4 |
2.756100E-03 |
| Stage1-vs-Stage2 |
4.014800E-01 |
| Stage1-vs-Stage3 |
9.594600E-04 |
| Stage1-vs-Stage4 |
1.776040E-03 |
| Stage2-vs-Stage3 |
8.625800E-02 |
| Stage2-vs-Stage4 |
1.806580E-01 |
| Stage3-vs-Stage4 |
9.670600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.93649607039515E-14 |
| Normal-vs-AfricanAmerican |
9.69239999999427E-05 |
| Normal-vs-Asian |
5.275600E-02 |
| Caucasian-vs-AfricanAmerican |
3.938400E-01 |
| Caucasian-vs-Asian |
8.361600E-02 |
| AfricanAmerican-vs-Asian |
2.923900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38777878078145E-14 |
| Normal-vs-Female |
7.46170000009982E-07 |
| Male-vs-Female |
2.838200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.70279999997825E-06 |
| Normal-vs-Extreme_Weight |
1.4954000004952E-07 |
| Normal-vs-Obese |
2.22279999961827E-07 |
| Normal-vs-Extreme_Obese |
4.439600E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.609010E-01 |
| Normal_Weight-vs-Obese |
7.259400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.899500E-03 |
| Extreme_Weight-vs-Obese |
7.567700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.834400E-02 |
| Obese-vs-Extreme_Obese |
1.657130E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.23723253864227E-12 |
| Normal-vs-Age(61-80Yrs) |
3.20469999981476E-07 |
| Normal-vs-Age(81-100Yrs) |
2.007500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.442400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.185700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.807560E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.242600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.246200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.299400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.84620121810053E-11 |
| Normal-VS-Type2 PRCC |
2.22689999995751E-07 |
| Normal-VS-KIRP CIMP |
9.448100E-04 |
| Normal-VS-Unclassified PRCC |
2.83339999995746E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.442300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.658400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.792220E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.704700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.346000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.481400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7675999999951E-05 |
| Normal-vs-N1 |
2.55760000000826E-06 |
| Normal-vs-N2 |
1.433200E-01 |
| N0-vs-N1 |
9.800100E-04 |
| N0-vs-N2 |
4.006400E-02 |
| N1-vs-N2 |
8.976200E-01 |
|
|
